AMRN – Amarin Corp ADR
Amarin Corporation plcAMRN
$13.69Name : Amarin Corporation plc
Sector : Healthcare
Industry: Drug Manufacturers - General
Mark. Cap: $284,651,840.00
EPSttm : -4.2
Amarin Corporation plc
$13.69
1.41%$0.19Float Short %
1.96
Margin Of Safety %
Put/Call OI Ratio
0.04
EPS Next Q Diff
EPS Last/This Y
4.22
EPS This/Next Y
0.37
Price
13.75
Target Price
12
Analyst Recom
4
Performance Q
-29.18
Relative Volume
0.58
Beta
0.84
Ticker: AMRN
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-08 | AMRN | 14.94 | 0.30 | 0.36 | 8361 |
| 2025-12-09 | AMRN | 14.17 | 0.30 | 0.44 | 8393 |
| 2025-12-10 | AMRN | 14.26 | 0.30 | 0.36 | 8457 |
| 2025-12-11 | AMRN | 14.47 | 0.30 | 0.06 | 8525 |
| 2025-12-12 | AMRN | 14.31 | 0.30 | 0.25 | 8589 |
| 2025-12-15 | AMRN | 14.13 | 0.30 | 3.33 | 8662 |
| 2025-12-16 | AMRN | 14 | 0.30 | 0.05 | 8662 |
| 2025-12-17 | AMRN | 13.75 | 0.30 | 2.15 | 8693 |
| 2025-12-18 | AMRN | 13.83 | 0.30 | 0.03 | 8679 |
| 2025-12-19 | AMRN | 13.79 | 0.31 | 0.21 | 8836 |
| 2025-12-22 | AMRN | 13.61 | 0.04 | 0.05 | 4232 |
| 2025-12-23 | AMRN | 13.62 | 0.04 | 0.00 | 4341 |
| 2025-12-26 | AMRN | 14.23 | 0.04 | 0.00 | 4360 |
| 2025-12-29 | AMRN | 14.04 | 0.04 | 0.00 | 5264 |
| 2025-12-30 | AMRN | 13.52 | 0.04 | 0.73 | 5526 |
| 2025-12-31 | AMRN | 14.01 | 0.04 | 0.28 | 5536 |
| 2026-01-02 | AMRN | 13.65 | 0.04 | 0.19 | 5551 |
| 2026-01-05 | AMRN | 13.51 | 0.04 | 0.37 | 5600 |
| 2026-01-06 | AMRN | 13.73 | 0.04 | 0.20 | 5709 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-08 | AMRN | 14.92 | 117.5 | - | 0.22 |
| 2025-12-09 | AMRN | 14.12 | 117.5 | - | 0.22 |
| 2025-12-10 | AMRN | 14.12 | 117.5 | - | 0.22 |
| 2025-12-11 | AMRN | 14.48 | 117.5 | - | 0.22 |
| 2025-12-12 | AMRN | 14.35 | 117.5 | - | 0.22 |
| 2025-12-15 | AMRN | 14.14 | 117.5 | - | 0.22 |
| 2025-12-16 | AMRN | 14.14 | 117.5 | - | 0.22 |
| 2025-12-17 | AMRN | 13.72 | 117.5 | - | 0.22 |
| 2025-12-18 | AMRN | 13.78 | 117.5 | - | 0.22 |
| 2025-12-19 | AMRN | 13.86 | 117.5 | - | 0.22 |
| 2025-12-22 | AMRN | 13.70 | 117.5 | - | 0.22 |
| 2025-12-23 | AMRN | 13.57 | 117.5 | - | 0.22 |
| 2025-12-26 | AMRN | 14.23 | 117.5 | - | 0.22 |
| 2025-12-29 | AMRN | 14.09 | 117.5 | - | 0.22 |
| 2025-12-30 | AMRN | 13.56 | 117.5 | - | 0.22 |
| 2025-12-31 | AMRN | 13.98 | 117.5 | - | 0.22 |
| 2026-01-02 | AMRN | 13.67 | 117.5 | - | 0.22 |
| 2026-01-05 | AMRN | 13.51 | 117.5 | - | 0.22 |
| 2026-01-06 | AMRN | 13.75 | 117.5 | - | 0.22 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-08 | AMRN | 0.00 | 3.15 | 1.91 |
| 2025-12-09 | AMRN | 0.00 | 3.15 | 1.91 |
| 2025-12-10 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-11 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-12 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-15 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-16 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-17 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-18 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-19 | AMRN | 0.00 | 3.15 | 2.01 |
| 2025-12-22 | AMRN | 0.00 | 3.14 | 2.01 |
| 2025-12-23 | AMRN | 0.00 | 3.14 | 2.01 |
| 2025-12-26 | AMRN | 0.00 | 3.14 | 1.96 |
| 2025-12-29 | AMRN | 0.00 | 3.14 | 1.96 |
| 2025-12-30 | AMRN | 0.00 | 3.14 | 1.96 |
| 2025-12-31 | AMRN | 0.00 | 3.14 | 1.96 |
| 2026-01-02 | AMRN | 0.00 | 3.14 | 1.96 |
| 2026-01-05 | AMRN | 0.00 | 3.15 | 1.96 |
| 2026-01-06 | AMRN | 0.00 | 3.15 | 1.96 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
0.07
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
3.15
Beta
0.84
Average Sales Estimate Current Quarter
50
Average Sales Estimate Next Quarter
42
Fair Value
Quality Score
34
Growth Score
26
Sentiment Score
47
Actual DrawDown %
92.6
Max Drawdown 5-Year %
-95.5
Target Price
12
P/E
Forward P/E
95.67
PEG
1.24
P/S
1.26
P/B
0.62
P/Free Cash Flow
EPS
-4.17
Average EPS Est. Cur. Y
0.22
EPS Next Y. (Est.)
0.59
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-37.87
Relative Volume
0.58
Return on Equity vs Sector %
-45.9
Return on Equity vs Industry %
-55.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.02
EBIT Estimation
Amarin Corporation plcSector: Healthcare
Industry: Drug Manufacturers - General
Employees: 275
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
stock quote shares AMRN – Amarin Corp ADR Stock Price stock today
news today AMRN – Amarin Corp ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch AMRN – Amarin Corp ADR yahoo finance google finance
stock history AMRN – Amarin Corp ADR invest stock market
stock prices AMRN premarket after hours
ticker AMRN fair value insiders trading